Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis
- PMID: 37427495
- PMCID: PMC10469350
- DOI: 10.1093/infdis/jiad261
Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis
Abstract
Background: Bacterial vaginosis (BV) is a common vaginal dysbiosis that often recurs following first-line antibiotics. We investigated if vaginal microbiota composition was associated with BV recurrence.
Methods: We analyzed samples and data from 121 women who participated in 3 published trials evaluating novel interventions for improving BV cure, including concurrent antibiotic treatment of regular sexual partners (RSPs). Women diagnosed with BV received first-line antibiotics and self-collected vaginal swabs pretreatment and the day after finishing antibiotics (immediately posttreatment). 16S rRNA gene sequencing was performed on vaginal samples. Logistic regression explored associations between BV recurrence and features of the vaginal microbiota pre- and posttreatment.
Results: Sixteen women (13% [95% confidence interval {CI}, 8%-21%]) experienced BV recurrence within 1 month of treatment. Women with an untreated RSP were more likely to experience recurrence than women with no RSP (P = .008) or an RSP who received treatment (P = .011). A higher abundance of Prevotella pretreatment (adjusted odds ratio [AOR], 1.35 [95% CI, 1.05-1.91]) and Gardnerella immediately posttreatment (AOR, 1.23 [95% CI, 1.03-1.49]) were associated with increased odds of BV recurrence.
Conclusions: Having specific Prevotella spp prior to recommended treatment and persistence of Gardnerella immediately posttreatment may contribute to the high rates of BV recurrence. Interventions that target these taxa are likely required to achieve sustained BV cure.
Keywords: Gardnerella; Prevotella; bacterial vaginosis; regular sexual partner; vaginal microbiota.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures

Similar articles
-
Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.BJOG. 2021 Mar;128(4):756-767. doi: 10.1111/1471-0528.16430. Epub 2020 Aug 16. BJOG. 2021. PMID: 33480468 Clinical Trial.
-
A novel Gardnerella, Prevotella, and Lactobacillus standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities.Front Cell Infect Microbiol. 2023 Jun 19;13:1198113. doi: 10.3389/fcimb.2023.1198113. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37404722 Free PMC article.
-
Microbial interactions among Gardnerella, Prevotella and Fannyhessea prior to incident bacterial vaginosis: protocol for a prospective, observational study.BMJ Open. 2024 Feb 5;14(2):e083516. doi: 10.1136/bmjopen-2023-083516. BMJ Open. 2024. PMID: 38316599 Free PMC article.
-
Characterization of the vaginal microflora in health and disease.Dan Med J. 2014 Apr;61(4):B4830. Dan Med J. 2014. PMID: 24814599 Review.
-
Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.Front Cell Infect Microbiol. 2020 Jan 10;9:452. doi: 10.3389/fcimb.2019.00452. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 31998661 Free PMC article. Review.
Cited by
-
Unveiling the dark side of Prevotella: a case of fatal pneumonia from a common probiotic.Front Med (Lausanne). 2024 Dec 24;11:1382134. doi: 10.3389/fmed.2024.1382134. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39776838 Free PMC article.
-
Characteristics of Vaginal Microbiota of Women of Reproductive Age with Infections.Microorganisms. 2024 May 20;12(5):1030. doi: 10.3390/microorganisms12051030. Microorganisms. 2024. PMID: 38792859 Free PMC article.
-
The human vaginal microbiota: from clinical medicine to models to mechanisms.Curr Opin Microbiol. 2024 Feb;77:102422. doi: 10.1016/j.mib.2023.102422. Epub 2024 Jan 11. Curr Opin Microbiol. 2024. PMID: 38215548 Free PMC article. Review.
-
Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis.NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):115. doi: 10.1038/s41522-025-00748-0. NPJ Biofilms Microbiomes. 2025. PMID: 40595711 Free PMC article. Review.
-
The Role of Prevotella Species in Female Genital Tract Infections.Pathogens. 2024 Apr 28;13(5):364. doi: 10.3390/pathogens13050364. Pathogens. 2024. PMID: 38787215 Free PMC article. Review.
References
-
- Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 2019; 46:304–11. - PubMed
-
- Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009; 3:CD006055. - PubMed
-
- Bradshaw CS, Morton AN, Hocking J, et al. . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193:1478–86. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous